microRNA‐133a regulates the cell cycle and proliferation of breast cancer cells by targeting epidermal growth factor receptor through the EGFR/Akt signaling pathway
暂无分享,去创建一个
Changliang Shan | Zhemin Zhou | Li Zhou | Zhemin Zhou | C. Shan | Shuai Zhang | Wenjing Cui | Li Zhou | Wenjing Cui | Shuai Zhang | Changliang Shan
[1] J. Downward,et al. Autophosphorylation sites on the epidermal growth factor receptor , 1984, Nature.
[2] C. Croce,et al. microRNA-205 regulates HER3 in human breast cancer. , 2009, Cancer research.
[3] Y. Huang,et al. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells , 2010, Oncogene.
[4] G. Stein,et al. A microRNA signature for a BMP2-induced osteoblast lineage commitment program , 2008, Proceedings of the National Academy of Sciences.
[5] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[6] A. Frump,et al. The synovial sarcoma SYT-SSX2 oncogene remodels the cytoskeleton through activation of the ephrin pathway. , 2007, Molecular biology of the cell.
[7] Nicolò Riggi,et al. Let-7a Is a Direct EWS-FLI-1 Target Implicated in Ewing's Sarcoma Development , 2011, PloS one.
[8] Ahmedin Jemal,et al. Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.
[9] J. Yun,et al. Effects of MicroRNA‐29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma , 2009, Hepatology.
[10] P. Rothberg,et al. Oncogenes and cancer. , 1983, Cancer investigation.
[11] R. Lloyd,et al. MicroRNA Expression in Ileal Carcinoid Tumors: Down-regulation of MicroRNA-133a with Tumor Progression , 2009, Modern Pathology.
[12] N. Seki,et al. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer , 2010, British Journal of Cancer.
[13] Jian-Rong Yang,et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. , 2009, Cancer research.
[14] Yunqing Li,et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. , 2008, Cancer research.
[15] Ahmedin Jemal,et al. Trends in Breast Cancer by Race and Ethnicity: Update 2006 , 2006, CA: a cancer journal for clinicians.
[16] Roy S Herbst,et al. Review of epidermal growth factor receptor biology. , 2004, International journal of radiation oncology, biology, physics.
[17] K. Pantel,et al. The interplay of HER2/HER3/PI3K and EGFR/HER2/PLC‐γ1 signalling in breast cancer cell migration and dissemination , 2012, The Journal of pathology.
[18] Cicek Gercel-Taylor,et al. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. , 2008, Gynecologic oncology.
[19] Robert A. Weinberg,et al. A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis , 2009 .
[20] Terry Hyslop,et al. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation , 2008, The Journal of cell biology.
[21] Sumit Arora,et al. miRNA-34b Inhibits Prostate Cancer through Demethylation, Active Chromatin Modifications, and AKT Pathways , 2012, Clinical Cancer Research.
[22] Yasutoshi Yamada,et al. Tumor suppressive microRNA-133a regulates novel targets: moesin contributes to cancer cell proliferation and invasion in head and neck squamous cell carcinoma. , 2012, Biochemical and biophysical research communications.
[23] Joseph O Deasy,et al. A microRNA expression signature for cervical cancer prognosis. , 2010, Cancer research.
[24] Diana M. Mitrea,et al. Cell cycle regulation by the intrinsically disordered proteins p21 and p27. , 2012, Biochemical Society transactions.
[25] M. Neri,et al. miR-1254 and miR-574-5p: Serum-Based microRNA Biomarkers for Early-Stage Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[26] N. Seki,et al. Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma , 2011, Journal of Human Genetics.
[27] Clay B Marsh,et al. MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. , 2009, Biochemical and biophysical research communications.
[28] T. Tuschl,et al. Identification of Tissue-Specific MicroRNAs from Mouse , 2002, Current Biology.
[29] Y. Okamoto,et al. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma. , 2012, International journal of oncology.
[30] D. Iliopoulos,et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. , 2008, Cancer cell.
[31] S. Nordeen,et al. MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents , 2009, Molecular Cancer Therapeutics.
[32] N. Seki,et al. 821 MIR-145 AND MIR-133A FUNCTION AS TUMOUR SUPPRESSORS AND DIRECTLY REGULATE FSCN1 EXPRESSION IN BLADDER CANCER , 2010 .
[33] N. Seki,et al. Novel molecular targets regulated by tumor suppressors microRNA-1 and microRNA-133a in bladder cancer. , 2012, International journal of oncology.
[34] Qiang Wang,et al. ErbB receptors: from oncogenes to targeted cancer therapies. , 2007, The Journal of clinical investigation.
[35] S. Safe,et al. MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. , 2010, Endocrinology.
[36] Lihong Ye,et al. miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3′UTR of CD46 , 2010, Cancer biology & therapy.
[37] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[38] Gregory J. Hannon,et al. microRNAs join the p53 network — another piece in the tumour-suppression puzzle , 2007, Nature Reviews Cancer.
[39] A. Krogh,et al. Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells* , 2008, Journal of Biological Chemistry.
[40] H. Skomedal,et al. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. , 1999, Gynecologic oncology.
[41] Yong Zhao,et al. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis , 2005, Nature.
[42] Jeffrey A. Engelman,et al. Targeting PI3K signalling in cancer: opportunities, challenges and limitations , 2009, Nature Reviews Cancer.
[43] Yvonne Tay,et al. MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation , 2008, Nature.
[44] Robert H. Jenkins,et al. MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis , 2013, The Journal of pathology.
[45] C. Croce. Oncogenes and cancer. , 2008, The New England journal of medicine.
[46] Marilyn E Morris,et al. MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells , 2009, Molecular Pharmacology.
[47] L. Suva,et al. Breast cancer metastasis to bone: it is not all about PTHrP. , 2003, Clinical orthopaedics and related research.
[48] X. Chen,et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.
[49] Stephanie Roessler,et al. MicroRNA expression, survival, and response to interferon in liver cancer. , 2009, The New England journal of medicine.
[50] M. Hung,et al. Survival of cancer cells is maintained by EGFR independent of its kinase activity. , 2008, Cancer cell.
[51] F. Slack,et al. Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.
[52] Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion , 2012, BMC Cancer.
[53] A. Schetter,et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers , 2009, Proceedings of the National Academy of Sciences.